What is 4D Molecular Therapeutics's common stock?

4D Molecular Therapeutics (FDMT) reported common stock of $5K in Q1 2026.

How has 4D Molecular Therapeutics's common stock changed year-over-year?

4D Molecular Therapeutics's common stock decreased by 0.0% year-over-year, from $5K to $5K.

What is the long-term trend for 4D Molecular Therapeutics's common stock?

Over 5 years (2020 to 2025), 4D Molecular Therapeutics's common stock has grown at a 14.9% compound annual growth rate (CAGR), from $3K to $6K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

4D Molecular Therapeutics FDMT Common Stock

Common Stock at other companies

Eli LillyLLY

$590M-0.4%

EyePoint, Inc. EYPT

$83K+20.3%

AbbVieABBV

$18M0.0%

RegenxbioRGNX

$5K0.0%

MeiraGTx Holdings plcMGTX

$3K0.0%

PVL

Palvella TherapeuticsPVLA

$14K+27.3%

Other financials

Income statement

See full

Revenue$3.0M+21,664%

Operating income-$73.6M-37.3%

Net income-$68.8M-43.3%

EPS (diluted)-$1.01-17.4%

Balance sheet

See full

Cash & equivalents$72.5M-45.7%

Total debt$20.5M-13.9%

Total equity$451.8M-3.8%

Total assets$512.9M-0.5%

Cash flow

See full

Operating cash flow-$68.1M-42.6%

CapEx--100%

Free cash flow-$68.1M-40.8%

Valuation

See full

Market cap$602.22M+215%

Enterprise value$550.27M+574%

P/S6.8×-8,306×

Profitability

See full

Operating margin-220.1%-110pp

Net margin-174,314.2%-62,763pp

FCF margin-154,209.2%-53,057pp

Returns & leverage

See full

Return on equity-45.4%+29.8pp

Debt / equity0×0.0×

Current ratio9.3×-3.0×

Where this comes from

Reported directly by 4D Molecular Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about 4D Molecular Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 4D Molecular Therapeutics's common stock?: 4D Molecular Therapeutics (FDMT) reported common stock of $5K in Q1 2026.
How has 4D Molecular Therapeutics's common stock changed year-over-year?: 4D Molecular Therapeutics's common stock decreased by 0.0% year-over-year, from $5K to $5K.
What is the long-term trend for 4D Molecular Therapeutics's common stock?: Over 5 years (2020 to 2025), 4D Molecular Therapeutics's common stock has grown at a 14.9% compound annual growth rate (CAGR), from $3K to $6K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).